Northern Trust’s CalciMedica CALC Stock Holding History

Northern Trust’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.77K	Hold	12,530	–	–	﹤0.01%	4384
2025 Q4	$82.6K	Buy	+12,530	New	+$48.9K	﹤0.01%	4172
2023 Q1	–	Sell	-1,150	Closed	-$8.05K	–	4584
2022 Q4	$8.05K	Hold	1,150	–	–	﹤0.01%	4594
2022 Q3	$15K	Hold	1,150	–	–	﹤0.01%	4591
2022 Q2	$18K	Hold	1,150	–	–	﹤0.01%	4639
2022 Q1	$20K	Hold	1,150	–	–	﹤0.01%	4668
2021 Q4	$29K	Hold	1,150	–	–	﹤0.01%	4677
2021 Q3	$53K	Buy	1,150 +296	+35%	+$16.6K	﹤0.01%	4529
2021 Q2	$65K	Sell	854 -4,196	-83%	-$275K	﹤0.01%	4442
2021 Q1	$393K	Sell	5,050 -258	-5%	-$77.2K	﹤0.01%	3894
2020 Q4	$2.16M	Buy	+5,308	New	+$1.57M	﹤0.01%	3161

Other funds holding CALC

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

1WA

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

SFFS

Stonehage Fleming Financial Services St. Helier, Jersey $2.75B AUM 13.81% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust's CALC Position: Q1 2026 in Review

Northern Trust held its CalciMedica (CALC) position steady in Q1 2026 at 12,530 shares worth $6.77K. The position accounts for ﹤0.01% of the portfolio, ranked #4384.

Northern Trust first reported a position in CALC in Q4 2020 and has held it in 11 quarters since. The position peaked at $2.16M in Q4 2020. 27 funds tracked by Wall St. Rank hold CALC as of Q1 2026.

Northern Trust held 12,530 shares of CalciMedica worth $6.77K as of Q1 2026.
Northern Trust left its CalciMedica share count unchanged in Q1 2026.
CalciMedica made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #4384 holding.
Northern Trust first reported a position in CalciMedica in Q4 2020 and has held it in 11 quarters since.
Northern Trust's CalciMedica position peaked at $2.16M in Q4 2020.
27 funds tracked by Wall St. Rank held CalciMedica as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.